Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

15th International Workshop on Chronic Lymphocytic Leukaemia (iwCLL 2013) /
Clinical highlights in CLL

9th - 11th Sep 2013

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 30.09.13
Views: 4559
Rating:

Prof Clemens Wendtner - Klinikum Schwabing, Munich, Germany

Professor Wendtner from Munich, Germany, talks to ecancer about highlights at this year’s iwCLL 2013.  He outlines the data he considers of most interest and importance clinically, including the excitement surrounding immunochemotherapy.  He then goes on to outline the therapies he sees as most promising over the next few years based on the latest identified cell targets.  Professor Wendtner gives an overview of the extensive clinical trial progromme on-going in his unit, which include those with elderly patients.  Finally, he gives advice to clinicians managing patients with CLL in their clinics.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation